ACADEMIA

• BBI608, BBI503 Exert Antitumor Activity in Multiple Studies: Sumitomo Dainippon
  June 3, 2015

• Pfizer, Merck KGaA Set to Leverage Complementary Tie-Up to Develop PD-L1 Inhibitor
  June 2, 2015

• Opdivo Shows OS Rate of 62% in HCC at 12 Months: ASCO
  June 1, 2015

• MHLW-Funded Study Calls for Use-Based Development Plans for Combination Drugs
  May 7, 2015

• Six Deaths Confirmed through Tofacitinib PMS, Guidelines Not Followed in All Cases
  April 30, 2015

• Biometric Society of Japan to Establish Certification System for Biostatisticians
  April 17, 2015

• Study Group Recommends “Reference Groups,” Dose-Escalation Studies to Promote Development of Ultra-Orphan Drugs
  April 8, 2015

• Medical University Association to Strengthen Collaboration with Industry
  April 3, 2015

• Stop Use of SGLT-2 Inhibitors, NSAIDs in Elderly: Japan Geriatrics Society
  April 3, 2015

• CRPC Drugs Xtandi, Zytiga Neck-and-Neck in Key Opinion Leader Poll
  April 1, 2015

• New Stroke Guidelines to “Strongly Recommend” NOACs for NVAF
  March 31, 2015

• Keytruda Demonstrates Superior OS, PFS to Yervoy in Advanced Melanoma in PIII Study: Merck
  March 30, 2015

• Univ. of Tokyo to Provide Access to Comprehensive Database of Drug and Medical Device Seeds Starting in April
  March 26, 2015

• Drug-Use Result Surveys Should Be Conducted in Elaborate Manner: Dr Narukawa
  March 25, 2015

• Yervoy Extends Survival of Terminal Melanoma Patients, Same Might Hold True for Other Immunotherapies: Prof.
  March 19, 2015

• Researcher Has High Hopes for Immunotherapies as Fourth Pillar of Cancer Treatment
  March 17, 2015

• Large-Scale Genomic Screening Project Gets Underway to Make Gene Database of 4,500 Cancer Patients
  March 12, 2015

• Urological Cancer Society to Be Inaugurated in October
  March 12, 2015

• Interview on SGLT-2 Inhibitor Use (2): Prof. Watada Calls for Caution in Analyzing EPPV Data
  March 9, 2015

• Interview on SGLT-2 Inhibitor Use (1): Prof. Ueki Says Flat Sales Reflect Cautious Prescribing by Physicians
  March 6, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• …
• Next ›
• 最終 »